8:45am ET
Investing
Buffett Grabs More of This Stock, Plus Other Notable Insider Buying
Warren Buffett boosted his stake in this tracking stock again, plus notable insider buying in the past week at biotechs, industrials and more.
Companies
/Healthcare
Aldeyra Therapeutics Inc
$1.49
▲ $0.00 (+0.00%) today
Markets closed · 11:45pm ET
Today · % change
Fundamentals
Market Cap
$89.9M
EPS (TTM)
$-0.38
52-Week Range
$1 – $6
Street Target
$6.60
About Aldeyra Therapeutics
Aldeyra Therapeutics Inc is a pioneering biotech firm focused on creating innovative treatments for immune-mediated diseases. Its flagship product, reproxalap, aims to alleviate dry eye diseases and is currently in advanced testing stages. The company is also exploring treatments for COVID-19, asthma, psoriasis, and alcohol intoxication through ADX-629, and tackling rare retinal diseases with ADX-2191. Founded in 2004 and based in Lexington, Massachusetts, Aldeyra is committed to addressing unmet medical needs in inflammation and vision loss.
ALDX Coverage
8:55am ET
Investing
Insiders Scoop Up Shares of These 5 Stocks for the Second Quarter
A renowned billionaire investor, a French energy giant, and other insiders were scooping up shares of these five stocks as the second quarter began.